Active form of prodrug: Dabigatran [DR:D09707]
Deep vein thrombosis after surgery, venous thromboembolic events, stroke prevention in atrial fibrillation
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AE Direct thrombin inhibitors
B01AE07 Dabigatran etexilate
D07082 Dabigatran etexilate mesylate (USAN) <JP/US>
USP drug classification [BR:br08302]
Blood Products and Modifiers
Anticoagulants
Direct Thrombin Inhibitors
Dabigatran
D07082 Dabigatran etexilate mesylate (USAN)
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
33 Blood and body fluid agents
333 Anticoagulants
3339 Others
D07082 Dabigatran etexilate mesylate (USAN); Dabigatran etexilate methanesulfonate (JAN)
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01511 Thrombin inhibitor
DG00164 Dabigatran
D07082 Dabigatran etexilate mesylate
DG03320 Direct oral anticoagulant (DOAC)
DG00164 Dabigatran
D07082 Dabigatran etexilate mesylate
Transporter substrate
DG01665 ABCB1 substrate
DG00164 Dabigatran
D07082 Dabigatran etexilate mesylate
Drug classes [BR:br08332]
Anticoagulant
DG03320 Direct oral anticoagulant (DOAC)
D07082 Dabigatran etexilate mesylate
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Serine peptidases
F2
D07082 Dabigatran etexilate mesylate (USAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D07082
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D07082
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D07082
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D07082
Drug metabolizing enzymes and transporters [br08309.html]
Drug transporters
D07082
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01511 Thrombin inhibitor
DG00164 Dabigatran
DG03320 Direct oral anticoagulant (DOAC)
DG00164 Dabigatran
Transporter substrate
DG01665 ABCB1 substrate
DG00164 Dabigatran